Literature DB >> 12542850

Lentiviral-mediated RNA interference.

Toufik Abbas-Terki1, William Blanco-Bose, Nicole Déglon, William Pralong, Patrick Aebischer.   

Abstract

RNA interference (RNAi) is a form of posttranscriptional gene silencing mediated by short double-stranded RNA, known as small interfering RNA (siRNA). These siRNAs are capable of binding to a specific mRNA sequence and causing its degradation. The recent demonstration of a plasmid vector that directs siRNA synthesis in mammalian cells prompted us to examine the ability of lentiviral vectors to encode siRNA as a means of providing long-term gene silencing in mammalian cells. The RNA-polymerase III dependent promoter (H1-RNA promoter) was inserted in the lentiviral genome to drive the expression of a small hairpin RNA (shRNA) against enhanced green fluorescent protein (EGFP). This construct successfully silenced EGFP expression in two stable cell lines expressing this protein, as analyzed by fluorescence microscopy, flow cytometry, and Western blotting. The silencing, which is dose dependent, occurs as early as 72 hr postinfection and persists for at least 25 days postinfection. The ability of lentiviruses encoding siRNA to silence genes specifically makes it possible to take full advantage of the possibilities offered by the lentiviral vector and provides a powerful tool for gene therapy and gene function studies.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12542850     DOI: 10.1089/104303402320987888

Source DB:  PubMed          Journal:  Hum Gene Ther        ISSN: 1043-0342            Impact factor:   5.695


  79 in total

1.  Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.

Authors:  Maciej Wiznerowicz; Didier Trono
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

Review 2.  Optimizing RNA interference for application in mammalian cells.

Authors:  René H Medema
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

Review 3.  Induction of RNA interference in dendritic cells.

Authors:  Mu Li; Hua Qian; Thomas E Ichim; Wei-Wen Ge; Igor A Popov; Katarzyna Rycerz; John Neu; David White; Robert Zhong; Wei-Ping Min
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 4.  Gene therapy in clinical medicine.

Authors:  S M Selkirk
Journal:  Postgrad Med J       Date:  2004-10       Impact factor: 2.401

5.  Optimization of feline immunodeficiency virus vectors for RNA interference.

Authors:  Scott Q Harper; Patrick D Staber; Christine R Beck; Sarah K Fineberg; Colleen Stein; Dalyz Ochoa; Beverly L Davidson
Journal:  J Virol       Date:  2006-10       Impact factor: 5.103

Review 6.  RNA interference in biology and disease.

Authors:  Carol A Sledz; Bryan R G Williams
Journal:  Blood       Date:  2005-04-12       Impact factor: 22.113

7.  Optimization and functional effects of stable short hairpin RNA expression in primary human lymphocytes via lentiviral vectors.

Authors:  Dong Sung An; F Xiao-Feng Qin; Vincent C Auyeung; Si Hua Mao; Sam K P Kung; David Baltimore; Irvin S Y Chen
Journal:  Mol Ther       Date:  2006-07-17       Impact factor: 11.454

8.  An inducible T7 RNA polymerase-dependent plasmid system.

Authors:  Matthias Hamdorf; Heide Muckenfuss; Ulrich Tschulena; Stephan Pleschka; Ralf Sanzenbacher; Klaus Cichutek; Egbert Flory
Journal:  Mol Biotechnol       Date:  2006-05       Impact factor: 2.695

9.  Lentiviral RNAi-induced downregulation of adenosine kinase in human mesenchymal stem cell grafts: a novel perspective for seizure control.

Authors:  Gaoying Ren; Tianfu Li; Jiang Quan Lan; Andrew Wilz; Roger P Simon; Detlev Boison
Journal:  Exp Neurol       Date:  2007-08-02       Impact factor: 5.330

10.  Efficient restricted gene expression in beta cells by lentivirus-mediated gene transfer into pancreatic stem/progenitor cells.

Authors:  M Castaing; A Guerci; J Mallet; P Czernichow; P Ravassard; R Scharfmann
Journal:  Diabetologia       Date:  2005-03-10       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.